Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 0 | 1,619 | 113 | 0 | 54,705 |
| Cost of Goods | N/A | 1,619 | 113 | N/A | 0 |
| Gross Profit | N/A | N/A | N/A | N/A | 54,705 |
| Operating Expenses | 286,582 | 291,623 | 157,971 | 86,329 | 45,901 |
| Operating Income | -286,582 | -291,004 | -157,858 | -86,329 | 8,804 |
| Interest Expense | 17,185 | 0 | 0 | 0 | 0 |
| Other Income | 7,338 | 2,125 | 1,604 | 859 | 104 |
| Pre-tax Income | -296,429 | -288,879 | -156,254 | -85,470 | 8,908 |
| Net Income Continuous | -296,429 | -288,879 | -156,254 | -85,470 | 8,908 |
| Net Income | $-296,429 | $-288,879 | $-156,254 | $-85,470 | $8,908 |
| EPS Basic Total Ops | -4.87 | -4.95 | -3.23 | -2.11 | 0.43 |
| EPS Basic Continuous Ops | -4.35 | -4.95 | -3.23 | -2.11 | 0.43 |
| EPS Diluted Total Ops | -4.87 | -4.95 | -3.23 | -2.11 | 0.30 |
| EPS Diluted Continuous Ops | -4.35 | -4.95 | -3.23 | -2.11 | 0.30 |
| EPS Diluted Before Non-Recurring Items | -4.87 | -4.95 | -3.23 | -2.11 | 0.30 |
| EBITDA(a) | $-284,015 | $-288,003 | $-156,184 | $-85,578 | $9,505 |